跳至主要内容
临床试验/IRCT138806301197N2
IRCT138806301197N2已完成未知

Effects of alpha lipoic acid supplementation on serum level of visfatin, markers of oxidative stress, inflammation and insulin resistance in patients with chronic renal failure undergoing hemodialysis.

utritional Research Center Tabriz University Of Medical Science0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 no limit(—)
性别
All

入选标准

  • obtaining informed consent, being on hemodialysis for more than 6 months, receiving 3 times hemodialysis each week
  • Exclusion criteria: hepatitis and other infections less than 20 years, receiving any NSAID and SAID, alpha lipoic acid supplement, vitamin C, vitamin E, valporic acid in the month prior to the study, presence of gastrointestinal disorders, being candidate for kidney transplantation, pregnancy or lactation, smoking, possibility of any side effect for consumption of the supplement

排除标准

  • 未提供

研究者

发起方
utritional Research Center Tabriz University Of Medical Science

相似试验